CURE Runners Italia

Published by
Published on
Experience as Alice Stance the thrilling story about the mysterious elixir CURE. Overcome the contaminated deserts in the zone, wing yourself through the industrial plants of Rayne City and fight yourself through jungle dens, in order to discover the real story behind the Raynecoat Corporation! Without you, the islands end is near!StoryCURE Runners tells the thrilling, ramified story about the mysterious elixir CURE, which can only be mined on Raynebow Island, a mysterious island in the middle of the Pacific Ocean. The Raynecoat Corporation is in control of the whole island and supplies the inhabitants with CURE. But disagreeable people are deported by Raynecoat to the zone, a contaminated desert area, from which there will be no escape. Or is there?You are Alice Stance, the runner, and have been deported after demonstrations against Raynecoat into the zone.Supply yourself with enough CURE, in order to succeed in finding the dangerous way back into Rayne City. Do you manage to illuminate Raynecoat Corporations sinister machinations and to restore the balance on the island? FEATURES- entirely free of charge game-fun, no commercial advertising, no in-app-purchases!- top graphic and realistic animations- Show your skills in a challenging game of skills!- Make use of various movements and skills in order to overcome obstacles- Experience innovative game-play-elements that are totally new for mobile jumpnruns- Enlighten a gloomy story about sinister machinations- Survive 15 days and achieve one of several different story-endings- Build your own gear and color it- Improve your rank and reputation in the master mode missions- Earn a highscore and measure yourself online with your friends
License Free
Version 1.4.2
Operating System iOS
System Requirements Compatible with: iphone3gs, iphone4, ipodtouchfourthgen, ipad2wifi, ipad23g, iphone4s, ipadthirdgen, ipadthirdgen4g, iphone5, ipodtouchfifthgen, ipadfourthgen, ipadfourthgen4g, ipadmini, ipadmini4g
Published by
Published on

ZDNET Latest Articles